Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX)

Q: What does CUSIP M40527109 represent in this 13F holders report?

CUSIP M40527109 is the security identifier for ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share used to aggregate holder disclosures.

Q: How many institutions held ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share in Q4 2024?

14 institutional investors reported ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share for Q4 2024. Use the holders table for investor-level position and value details.

CUSIP: M40527109

Q4 2024 13F Holders as of 31 Dec 2024

Security type / class: Equity / Ordinary shares, par value NIS 0.0000769 per share
Shares outstanding: 45,504,462
Total 13F shares: 7,494,222
Share change: +2,170,994
Total reported value: $15,902,006
Put/Call ratio: 0%
Reported price per share: $2.12
Number of holders: 14
Value change: +$4,661,706
Number of buys: 7
Number of sells: 7

Security key

M40527109

Report period

Q4 2024

Institutions

Top holders

ENTX full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2025 Previous quarter: Q3 2024 Entera Bio Ltd. SEC filings Entera Bio Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP M40527109

Newer quarter: Q1 2025 Previous quarter: Q3 2024

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

Knoll Capital Management,...

13D/G signal

—

Evidence rows

Latest as of

30 Sep 2024

13F 3/4/5 Lead comparable stake: 8.5% Showing 1-6 of 15 holder rows.

Rank 1 holder

Knoll Capital Management, LLC

13F 3/4/5

Ownership: 8.5%
Position: $7.38M

13F 3/4/5

Rank 2 holder

Schonfeld Strategic Advisors LLC

13F

Ownership: 1.4%
Position: $1.23M

13F

Rank 3 holder

Parkman Healthcare Partners LLC

13F

Ownership: 0.9%
Position: $781K

13F

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Knoll Capital Management, LLC	13F 3/4/5 Company · 10%+ Owner 13F 3/4/5	8.5%	$7,375,570 3,881,879 shares	—	30 Sep 2024
Schonfeld Strategic Advisors LLC	13F Company 13F	1.4%	$1,232,340 648,600 shares	—	30 Sep 2024
Parkman Healthcare Partners LLC	13F Company 13F	0.9%	$781,044 411,076 shares	—	30 Sep 2024
UBS Group AG	13F Company 13F	0.31%	$271,220 142,747 shares	—	30 Sep 2024
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	0.13%	$116,280 61,200 shares	—	30 Sep 2024
SIGNATURE ESTATE & INVESTMENT ADVISORS LLC	13F Company 13F	0.1%	$89,923 47,328 shares	—	30 Sep 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

7,494,222

Rows available

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders

Q4 2024 holders

Holder diff

-3

Investor	Q3 2024 Shares	Q4 2024 Shares	Share Diff	Share Chg %	Q3 2024 value	Q4 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend